Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selmevit for Thrombosis Risk Reduction in Women on COCs
NCT02027337Phase 4Unknown
- Sponsor
- Tyumen State Medical University
- Start
- Dec 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Selmevit in polycystic ovary syndrome (PCOS), hyperandrogenism, Menstrual irregularities, sponsored by Tyumen State Medical University. Status: unknown.
02
Drugs
Selmevit
03
Conditions
polycystic ovary syndrome (PCOS)hyperandrogenismMenstrual irregularities
Beyond the preview
Go deeper on NCT02027337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02027337.